Kimberly-Clark Reaches New 52-Week High (KMB)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Kimberly-Clark Corporation (NYSE: KMB) hit a new 52-week high Thursday as it is currently trading at $102.30, above its previous 52-week high of $102.03 with 740,660 shares traded as of 11 a.m. ET. Average volume has been 2.3 million shares over the past 30 days.

Kimberly-Clark has a market cap of $39.29 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 19.2% year to date as of the close of trading on Wednesday.

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care, consumer tissue, and health care products worldwide. The company operates in four segments: Personal Care, Consumer Tissue, K-C Professional, and Health Care. The company has a P/E ratio of 23, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Kimberly-Clark as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins, notable return on equity and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Kimberly-Clark Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.
null

If you liked this article you might like

Crazy Weak U.S. Dollar Will Make These 10 Companies Huge Winners

Equifax CEO and Board Are Pretty Cozy

Ridiculously Weak U.S. Dollar Will Make These 10 Companies Huge Winners

Johnson & Johnson, 3M and 8 Other Winners From the Ridiculously Weaker Dollar

Equifax Board Faces Scrutiny as Probes Mount Following Cyberattack